Interruption 2015
Rode Strawther
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it provides criteria with benchmarks, where possible, for all key aspects of leprosy programmes and services. Not only those related to elimination efforts, but also those related to diagnosis and management of leprosy, leprosy-related disabilities, mental wellbeing, stigma and discrimination and inclusion and participation of persons affected by leprosy. The document emphasises that the elimination of leprosy is a long-term, continuous journey on the one hand, while, on the other, clear milestones can be recognised on the way and programme implementation can be assessed against benchmarks, guiding appropriate action to keep the programme on track.
Additionally, business interruption policies may contain a clause for civil authority coverage. If a local, state, or federal government entity prohibits access to the business premises, and thereby forces businesses to temporarily close, BI insurance may cover lost income through a civil authority clause. The civil authority provision in a standard BI policy form issued by the Insurance Services Office (ISO) stipulates certain provisions be met to trigger coverage:
In addition to civil authority coverage, there are two more types of business interruption insurance policies: contingent business interruption and extended business interruption. These are optional coverages that are available as riders to a standard business interruption policy.
Insurers started excluding viral and bacterial infections from their BI policies after the SARS (Severe Acute Respiratory Syndrome) outbreak in 2003 caused massive losses to insurers, including a $16 million BI payout to Mandarin Oriental, a hotel chain in Asia. In 2006 the Insurance Services Office (ISO) developed an exclusion for losses due to virus or bacteria. Since then, many insurers have edited their policy language to specifically exclude bacterial and viral outbreaks.
Pandemics are viewed by the insurance industry as uninsurable events because they affect policyholders everywhere at the same time. Experts posit that only the federal government has the financial resources necessary to cover pandemic risks.
Other representatives also introduced legislation relating to insurance and pandemics. On April 14, 2020, Rep. Mike Thompson (D-CA) introduced H.R. 6494, the Business Interruption Coverage Act of 2020.The legislation appears to be retroactive in nature and would require insurers who provide BI coverage to include losses from pandemics or government-ordered business closure. Another bill, H.R. 6497, the Never Again Small Business Protection Act, proposed by Rep. Brian Fitzpatrick (R-PA), also requires insurers to cover losses associated with viruses or pandemics, but it includes a provision requiring a federal reinsurance backstop. On May 20, 2020, the NAIC submitted a letter to the U.S. House Committee on Small Business opposing proposals that would require insurers to retroactively pay claims for COVID-19 claims.
According to the Allianz Risk Barometer, business interruption insurance (31%) is one of the top three global business risks in 2024, along with cyber incidents (36%) and natural catastrophes (26%). It will be important to monitor continuing developments in the BI sphere, especially as lawsuits from larger companies and organizations move forward. Larger corporations usually have more tailored policies that do not always include specific virus-specific exclusions that smaller businesses commonly incorporate into their contracts. The Penn State Covid Coverage Litigation Tracker, which updates statistics in Covid-related BI litigation, has found most courts have so far ruled in favor of insurers in motions to dismiss or for summary judgment. In 2021 only one case, Hopps Ltd. vs. Cincinnati Insurance Co., moved to a jury trial. In late October 2021, the jury rendered a verdict for the defendant in the first jury trial for Covid business interruption losses.
Status: On March 25, 2020, the NAIC released a statement on Congressional actions related to COVID-19 and the insurance industry. In the statement, the NAIC opposed proposed legislation that would require insurance companies to retroactively pay for claims arising out of the COVID-19 pandemic losses that were not covered under the original policy, arguing that such actions could create a substantial solvency risk and undermine the ability of insurers to pay other types of claims. Further, the NAIC noted that insurance is not the ideal product to cover pandemic losses, due to the widespread nature of disease and the substantial number of policyholders affected simultaneously. Instead, the NAIC recommended direct federal intervention to address economic disruption related to the current COVID-19 pandemic and offered to work with Congress on potential solutions.
In May 2020, state insurance regulators, through the NAIC, developed and issued a data call to collect business interruption information from insurers. This data will assist state insurance regulators and others in understanding which insurers are writing applicable coverage, the size of the market, and the extent of exclusions related to COVID-19. Preliminary results show that nearly 8 million commercial insurance policies include business interruption coverage. Of that amount, 90% were for small businesses with100 or fewer employees, 8% for medium businesses, and 2% for large businesses withmore than 500 employees. Significantly, 83% of all policies included an exclusion for viral contamination, virus, disease, or pandemic and 98% of all policies had a requirement for physical loss. Exclusions and physical loss requirements were slightly more likely to occur in small business policies as compared to large business policies. Insurance regulators are also regularly collecting loss and claims data to obtain a sense of how claims are developing and the extent of payments by insurers.
Hachimura will play in just his 60th career game Friday in a second straight bout against the Heat, and Avdija has played in just 14, yet both are starting, and both have faced unprecedented interruption to their young careers.
Please note: The COVID-19 pandemic-related diploma was initially set to automatically expire on September 1, 2023 but has been extended as a result of LD 873 "An Act to Continue the Department of Education Diploma Program Related to the COVID-19 Pandemic". The pandemic-related diploma program is now set to expire on September 1, 2026.
A 4th-year secondary student who is unable to obtain a locally awarded diploma due to the significant interruption of education resulting from the COVID-19 pandemic and civil emergency may apply for this diploma if they can provide evidence that they have fulfilled the following core state requirements:
You can launch Spot Instances on spare EC2 capacity for steep discounts in exchange for returningthem when Amazon EC2 needs the capacity back. When Amazon EC2 reclaims a Spot Instance, we call this eventa Spot Instance interruption.
Demand for Spot Instances can vary significantly from moment to moment, and the availability of Spot Instancescan also vary significantly depending on how many unused EC2 instances are available. Itis always possible that your Spot Instance might be interrupted.
The site is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The Food and Drug Administration (FDA or Agency) is issuing this guidance to address section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as added by section 3121 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), Pub. L. No. 116-136 (March 2020), as it relates to notifying FDA of a permanent discontinuance or interruption in the manufacturing of a device that is likely to lead to a meaningful disruption in the supply of that device during or in advance of a public health emergency (PHE).
FDA plays a critical role in protecting the United States from threats, such as emerging infectious diseases, and other PHEs. Section 506J requires manufacturers to notify FDA, during or in advance of a PHE, of a permanent discontinuance in the manufacture of certain devices or an interruption in the manufacture of certain devices that is likely to lead to a meaningful disruption in supply of that device in the United States. This guidance is intended to assist manufacturers in providing timely, informative notifications about changes in the production of certain medical devices that will help prevent or mitigate shortages of such devices. This guidance also recommends that manufacturers voluntarily provide additional information to better ensure FDA has the specific information it needs to help prevent or mitigate shortages during or in advance of a PHE.
You can specify the interruption behavior when you create a Spot request. If you do notspecify an interruption behavior, the default is that Amazon EC2 terminates Spot Instanceswhen they are interrupted.
If you request Spot Instances using the launchinstance wizard, you can specify the interruption behavior asfollows: In the launch instance wizard, expand Advanceddetails and select the Request Spot Instancescheck box. Choose Customize. FromInterruption behavior, choose an interruptionbehavior. If the interruption behavior is hibernation, you canalternatively choose Enable for Stop -Hibernate behavior.
If you request Spot Instances using the run-instances CLI, you can specify the interruptionbehavior as follows: In the request configuration,(--instance-market-options), forInstanceInterruptionBehavior, specify an interruptionbehavior. If the interruption behavior is hibernate, youcan alternatively enable hibernation using the--hibernation-options Configured=true parameter.
c80f0f1006